08:00 , Jan 5, 2015 |  BC Week In Review  |  Financial News

CardioDx completes venture financing

CardioDx Inc. , Palo Alto, Calif.   Business: Diagnostic   Date completed: 2014-12-18   Type: Venture financing   Raised: $35 million   Investors: Alberta Investment Management; existing investors  ...
08:00 , Jan 5, 2015 |  BC Week In Review  |  Financial News

CardioDx withdraws IPO

CardioDx Inc. , Palo Alto, Calif.   Business: Diagnostic   Date announced: 2014-12-23   Type: IPO   Underwriters: Jefferies; Piper Jaffray; William Blair   Note: CardioDx withdrew its planned IPO on NASDAQ, citing market conditions....
02:52 , Dec 24, 2014 |  BC Extra  |  Financial News

CardioDx withdraws IPO

CardioDx Inc. (Palo Alto, Calif.) withdrew its IPO on NASDAQ, citing market conditions. In April, the company revived plans for an IPO it had postponed the previous fall, but it did not set terms (see...
01:47 , Aug 20, 2014 |  BC Extra  |  Financial News

Dermatology play Dermira raises $51 million in series C

Dermira Inc. (Redwood City, Calif.) raised $51 million in a series C round and announced a number of management changes and board appointments. The C round came from existing investors Bay City Capital; New Enterprise...
07:00 , Jul 14, 2014 |  BC Week In Review  |  Clinical News

Corus CAD regulatory update

CardioDx said that health care benefits companies Aetna Inc. and Aetna’s Coventry Health Care Inc. will cover CardioDx’s Corus CAD gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in non-diabetic...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

CardioDx board of directors update

CardioDx Inc. , Palo Alto, Calif.   Business: Diagnostic   Appointed: CFO Andrew Guggenhime; and James Tobin, formerly president and CEO of Boston Scientific Corp.  ...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

CardioDx management update

CardioDx Inc. , Palo Alto, Calif.   Business: Diagnostic   Hired: Melinda Griffith as head of corporate development and general counsel, formerly SVP of business development and product strategy at Clarient Inc. , which General...
07:00 , May 5, 2014 |  BC Week In Review  |  Financial News

CardioDx amends IPO

CardioDx Inc. , Palo Alto, Calif.   Business: Diagnostic   Date announced: 4/28/14   Type: IPO   To be raised: TBD   Shares: TBD   Price: TBD   Underwriter: Jefferies; Piper Jaffray; William Blair  ...
00:43 , Apr 30, 2014 |  BC Extra  |  Financial News

CardioDx revives IPO plans

CardioDx Inc. (Palo Alto, Calif.) revived plans for an IPO on NASDAQ. The company had planned to sell 5 million shares at $14-$16 and would have raised $75 million at the $15 midpoint. In November,...
08:00 , Nov 18, 2013 |  BC Week In Review  |  Financial News

CardioDx postpones IPO

CardioDx Inc. , Palo Alto, Calif.   Business: Diagnostic   Date announced: 11/15/13   Type: IPO   Underwriters: BofA Merrill Lynch; Jefferies; Piper Jaffray; William Blair   Note: The company postponed its IPO due to...